Ocugen is trading at $0.93, 5.03% up in pre-market on October 14, with no confirmed catalyst identified. - The October 13 close was $0.89. - No fresh company announcement clearly explains the move. Major indices are nearly unchanged, offering no clear explanation for the gain. - Recent coverage reported that CEO Shankar Musunuri sold shares on October 9 under a previously adopted Rule 10b5-1 plan; that transaction does not establish a reason for this morning’s rise.